Goulven Theze

Goulven THEZE, MBA, is a seasoned professional in oncology and healthcare innovation, currently serving as the Head of Business Development & Innovation at Unicancer, specializing in Real World Data and strategic partnerships. Prior roles include Head of Innovation and Valorization at Hôpital Fondation Adolphe de Rothschild, where responsibilities encompassed business development, financial modeling, and project coordination in cell and gene therapy, alongside managing numerous research and strategic contracts. Previous experience includes key positions at Bayer Pharmaceuticals, Le Belvedere, Statitec, ICON plc, and Harrison Clinical Research, where Goulven developed expertise in market access, pricing strategies, and health economics. Goulven holds an MBA in Global Management and Health Economics from ESSEC Business School.